Showing results (211-220 of 266) with videos related to
Sort By:
Pageof 27
The Journal of Clinical Psychiatry|April 1, 1981
Hemoperfusion for chronic schizophrenia: preliminary psychiatric resultsM J Kinney, E Varga, V Varga, et al.Biochimica Et Biophysica Acta|April 25, 1989
Clot uptake of labeled active and inhibited tissue plasminogen activatorE Lavie, M Bitton, J Shalev, et al.Journal of Clinical Psychopharmacology|December 1, 1990
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administrationG M Simpson, K G Yadalam, D F Levinson, et al.Acta Physiologica Hungarica|January 1, 1996
On the cardioprotective effect of adenosineJ Z Szabó, E Varga, K Nosztray, et al.Cellular and Molecular Neurobiology|February 22, 2018
Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple SclerosisE Varga, E Pandur, H Abrahám, et al.The Journal of Clinical Psychiatry|August 29, 1998
Absence of changes in antidiuretic hormone, angiotensin II, and atrial natriuretic peptide with clozapine treatment of polydipsia-hyponatremia: 2 case reportsC Verghese, G Abraham, C Nair, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 11, 2005
Radioactivity of the Bega sediment-case study of a contaminated canalI Bikit, E Varga, Lj Conkić, et al.Acta Pharmaceutica Hungarica|May 1, 1994
[Cardioprotective effect of levcromakalim in isolated guinea pig heart preparations]K Guba, E Varga, K Nosztray, et al.Lipids in Health and Disease|October 21, 2016
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemiaViktória E Varga, Hajnalka Lőrincz, Noémi Zsíros, et al.The American Journal of Psychiatry|May 1, 1995
Fluphenazine plasma levels, dosage, efficacy, and side effectsD F Levinson, G M Simpson, E S Lo, et al.Pageof 27